In 2022, chronic lower respiratory disease was the sixth highest cause of death in the U.S., according to results published ...

Researchers developed a new COPD-ES questionnaire for healthcare professionals to improve the management of stable chronic ...

Qureight Ltd and Avalyn Pharma Inc have announced a strategic partnership in progressive pulmonary fibrosis (PPF). The ...

Among adults hospitalized with influenza, Tamiflu treatment on the day of hospital admission was associated with a reduced risk for disease progression.

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

The following is a summary of “Feasibility, Usability, and Pilot Efficacy Study of a Software-Enabled, Virtual Pulmonary ...

Announcing a new article publication for Zoonoses journal. This study was aimed at exploring pulmonary tuberculosis (PTB) epidemiological characteristics and trends in China from 2016 to 2022, to ...

Harvard Health explains: "Power naps allow your body and mind to rest without entering deeper stages of sleep. Once you enter ...

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases in the U.S.

Learn more about whether Amedisys, Inc. or The Ensign Group, Inc. is a better investment based on AAII's A+ Investor grades, ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

There would be great concerns about the agreement between General and French COPD by the Government, which required guarantees regarding ...